secwatch.observer — SEC 8-K summary
======================================

Issuer:     Altimmune, Inc. (ALT)
CIK:        0001326190
Form:       8-K
Filed at:   2026-02-03T23:59:59+00:00
Accession:  0001326190-26-000008
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Altimmune sets 2026 annual meeting for April 16; proposal deadline Feb 13
-------------------------------------------------------------------------

- Annual meeting scheduled for April 16, 2026; record date is March 13, 2026.
- Stockholder proposals for inclusion in proxy must be received by February 13, 2026.
- Director nominations under bylaws and universal proxy rule due by February 13 and February 15, 2026, respectively.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326190/000132619026000008/0001326190-26-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326190/000132619026000008/alt-20260202x8k.htm
  HTML page:      https://secwatch.observer/filing/0001326190-26-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer